1. Home
  2. PEBO vs GRI Comparison

PEBO vs GRI Comparison

Compare PEBO & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peoples Bancorp Inc.

PEBO

Peoples Bancorp Inc.

HOLD

Current Price

$31.37

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$0.52

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEBO
GRI
Founded
1902
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
4.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PEBO
GRI
Price
$31.37
$0.52
Analyst Decision
Buy
Strong Buy
Analyst Count
6
2
Target Price
$34.58
$23.00
AVG Volume (30 Days)
149.2K
1.2M
Earning Date
01-20-2026
11-14-2025
Dividend Yield
5.24%
N/A
EPS Growth
N/A
N/A
EPS
2.86
N/A
Revenue
$555,347,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.07
N/A
P/E Ratio
$10.95
N/A
Revenue Growth
10.92
N/A
52 Week Low
$26.21
$0.50
52 Week High
$35.12
$16.66

Technical Indicators

Market Signals
Indicator
PEBO
GRI
Relative Strength Index (RSI) 68.32 22.14
Support Level $30.14 $0.50
Resistance Level $31.53 $2.17
Average True Range (ATR) 0.51 0.19
MACD 0.19 -0.16
Stochastic Oscillator 95.82 0.85

Price Performance

Historical Comparison
PEBO
GRI

About PEBO Peoples Bancorp Inc.

Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

Share on Social Networks: